MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) shot up 2.4% on Tuesday . The stock traded as high as $1.39 and last traded at $1.34. 12,783 shares were traded during trading, a decline of 90% from the average session volume of 134,123 shares. The stock had previously closed at $1.31.
MyMD Pharmaceuticals Price Performance
The business has a fifty day simple moving average of $1.57 and a 200-day simple moving average of $1.91.
About MyMD Pharmaceuticals
MyMD Pharmaceuticals, Inc, a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system and its pro-inflammatory cytokines to prevent and treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for sarcopenia, multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis; inflammation related depression and anxiety; and COVID-19-associated depression.
Recommended Stories
- Five stocks we like better than MyMD Pharmaceuticals
- Energy and Oil Stocks Explained
- Palantir Cracks $50, Is There Still Time to Get on Board?
- About the Markup Calculator
- Insider Buying Signals Upside for These 3 Stocks
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for MyMD Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MyMD Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
